BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7543051)

  • 1. Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma.
    Dumont FJ; Fischer P; Sirotina A
    Exp Cell Res; 1995 Jul; 219(1):146-58. PubMed ID: 7543051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma.
    Dumont FJ; Staruch MJ; Grammer T; Blenis J; Kastner CA; Rupprecht KM
    Cell Immunol; 1995 Jun; 163(1):70-9. PubMed ID: 7538911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
    Dumont FJ; Kastner CA
    J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
    Radvanyi LG; Shi Y; Mills GB; Miller RG
    Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin resistance in ataxia-telangiectasia.
    Beamish H; Williams R; Chen P; Khanna KK; Hobson K; Watters D; Shiloh Y; Lavin M
    Oncogene; 1996 Sep; 13(5):963-70. PubMed ID: 8806686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
    J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC; Parr R; Belyavskyi M; Summers MD
    Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of LFA-1 (CD11a/CD18) cytoplasmic domains in binding to intercellular adhesion molecule-1 (CD54) and in postreceptor cell spreading.
    Pyszniak AM; Carpenito C; Takei F
    Exp Cell Res; 1997 May; 233(1):78-87. PubMed ID: 9184078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes.
    Terada N; Takase K; Papst P; Nairn AC; Gelfand EW
    J Immunol; 1995 Oct; 155(7):3418-26. PubMed ID: 7561036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant-negative effect of the lymphocyte function-associated antigen-1 beta (CD18) cytoplasmic domain on leukocyte adhesion to ICAM-1 and fibronectin.
    Rey-Ladino JA; Pyszniak AM; Takei F
    J Immunol; 1998 Apr; 160(7):3494-501. PubMed ID: 9531311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TABS, a T cell activation antigen that induces LFA-1-dependent aggregation.
    Andrew DP; Yoshino T; Guh L; Martin-Simonet MT; Butcher EC
    J Immunol; 1995 Aug; 155(4):1671-84. PubMed ID: 7543529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes.
    Damle NK; Klussman K; Leytze G; Aruffo A; Linsley PS; Ledbetter JA
    J Immunol; 1993 Sep; 151(5):2368-79. PubMed ID: 7689606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD; Lerner CG; Schwartz RH
    J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement of the CD45 molecule induces homotypic adhesion of human thymocytes through a LFA-1/ICAM-3-dependent pathway.
    Bernard G; Zoccola D; Ticchioni M; Breittmayer JP; Aussel C; Bernard A
    J Immunol; 1994 Jun; 152(11):5161-70. PubMed ID: 8189044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirements for LFA-1 binding to ICAM-1 and LFA-1-mediated cell aggregation.
    Petruzzelli L; Maduzia L; Springer TA
    J Immunol; 1998 May; 160(9):4208-16. PubMed ID: 9574521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off.
    Greenwood J; Wang Y; Calder VL
    Immunology; 1995 Nov; 86(3):408-15. PubMed ID: 8550078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of lymphocyte function-associated molecule-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) mimicked by an antibody directed against CD18.
    Petruzzelli L; Maduzia L; Springer TA
    J Immunol; 1995 Jul; 155(2):854-66. PubMed ID: 7608563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lck tyrosine kinase is important for activation of the CD11a/CD18-integrins in human T lymphocytes.
    Fagerholm S; Hilden TJ; Gahmberg CG
    Eur J Immunol; 2002 Jun; 32(6):1670-8. PubMed ID: 12115650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2.
    Feuerstein N; Huang D; Hinrichs SH; Orten DJ; Aiyar N; Prystowsky MB
    J Immunol; 1995 Jan; 154(1):68-79. PubMed ID: 7995960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.